基因组定向编辑技术的专利概述及其对高校创新创业教育的启示

doi:10.16288/j.yczz.15-263

[an error occurred while processing this directive]

HEREDITAS(Beijing) ›› 2015, Vol. 37 ›› Issue (12): 1258-1262.doi: 10.16288/j.yczz.15-263

• Genetics Teaching • Previous Articles

Overview of patents on targeted genome editing technologies and their implications for innovation and entrepreneurship education in universities

Xiangyu Fan^{1, 2}, Yanping Lin¹, Guojian Liao³, Jianping Xie¹

1. Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-environments in the Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Beibei 400715, China;
2. School of Biological Science and Technology, University of Jinan, Jinan 250022, China;
3. Institute of Modern Biopharmaceuticals, School of Pharmaceutical Sciences, Southwest University, Beibei 400715, China

Received:2015-06-03 Online:2015-12-20 Published:2015-08-12

Abstract

Abstract: Zinc finger nuclease, transcription activator-like effector nuclease, and clustered regularly interspaced short palindromic repeats/Cas9 nuclease are important targeted genome editing technologies. They have great significance in scientific research and applications on aspects of functional genomics research, species improvement, disease prevention and gene therapy. There are past or ongoing disputes over ownership of the intellectual property behind every technology. In this review, we summarize the patents on these three targeted genome editing technologies in order to provide some reference for developing genome editing technologies with self-owned intellectual property rights and some implications for current innovation and entrepreneurship education in universities.

Key words: ZFN, TALEN, CRISPR/Cas, intellectual property

Xiangyu Fan, Yanping Lin, Guojian Liao, Jianping Xie. Overview of patents on targeted genome editing technologies and their implications for innovation and entrepreneurship education in universities[J]. HEREDITAS(Beijing), 2015, 37(12): 1258-1262.

References

[1] Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA , 1996, 93 (3): 1156-1160.
[2] 钟强, 赵书红. 锌指蛋白核酸酶的作用原理及其应用. 遗传, 2011, 33 (2): 123-130.
[3] 肖安, 胡莹莹, 王唯晔, 杨志芃, 王展翔, 黄鹏, 佟向军, 张博, 林硕. 人工锌指核酸酶介导的基因组定点修饰技术. 遗传, 2011, 33 (7): 665-683.
[4] 沈延, 肖安, 黄鹏, 王唯晔, 朱作言, 张博. 类转录激活因子效应物核酸酶(TALEN)介导的基因组定点修饰技术. 遗传, 2013, 35 (4): 395-409.
[5] Kay S, Hahn S, Marois E, Hause G, Bonas U. A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science , 2007, 318 (5850): 648-651.
[6] Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics , 2010, 186 (2): 757-761.
[7] Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas D F. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res , 2011, 39 (12): e82.
[8] Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science , 2012, 337 (6096): 816-821.
[9] 殷利眷, 胡斯奇, 郭斐. CRISPR-Cas9基因编辑技术在病毒感染疾病治疗中的应用. 遗传, 2015, 37(5): 412-418.
[10] Chandrasekharan S, Kumar S, Valley CM, Rai A. Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins. Natbiotechnoly , 2009, 27 (2): 140-144.
[11] Maeder M L, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RJ, Townsend JA, Unger-Wallace E, Sander JD, Muller-Lerch F, Fu FL, Pearlberg J, GÖbel C, Dassie JP, Pruett-Miller SM, Porteus MH, Sgroi DC, Iafrate AJ, Dobbs D, McCray PB Jr, Cathomen T, Voytas DF, Joung JK. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell , 2008, 31 (2): 294-301.
[12] 樊祥宇, 廖国建, 谢建平. 以CRISPR/Cas9专利为例的知识产权教育. 遗传, 2014, 36 (12): 1269-1273.
[13] Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science , 2013, 339(6121): 819-823.

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

[1]	Bingzheng Wang, Chao Zhang, Jiali Zhang, Jin Sun. Conditional editing of the Drosophila melanogaster genome using single transcripts expressing Cas9 and sgRNA [J]. Hereditas(Beijing), 2023, 45(7): 593-601.
[2]	Danni Liu, Haiping Wu, Guohua Zhou. Research progress of visual detection in rapid on-site detection of pathogen nucleic acid [J]. Hereditas(Beijing), 2023, 45(4): 306-323.
[3]	Meizhen Liu, Liren Wang, Yongmei Li, Xueyun Ma, Honghui Han, Dali Li. Generation of genetically modified rat models via the CRISPR/Cas9 technology [J]. Hereditas(Beijing), 2023, 45(1): 78-87.
[4]	Xiaojun Zhang, Kun Xu, Juncen Shen, Lu Mu, Hongrun Qian, Jieyu Cui, Baoxia Ma, Zhilong Chen, Zhiying Zhang, Zehui Wei. A CRISPR/Cas9-Gal4BD donor adapting system for enhancing homology-directed repair [J]. Hereditas(Beijing), 2022, 44(8): 708-719.
[5]	Chong Zhang, Zixuan Wei, Min Wang, Yaosheng Chen, Zuyong He. Editing MC1R in human melanoma cells by CRISPR/Cas9 and functional analysis [J]. Hereditas(Beijing), 2022, 44(7): 581-590.
[6]	Shaozheng Song, Zhengyi He, Yong Cheng, Baoli Yu, Ting Zhang, Dan Li. MSTN modification in goat mediated by TALENs and performance analysis [J]. Hereditas(Beijing), 2022, 44(6): 531-542.
[7]	Yao Liu, Xianhui Zhou, Shuhong Huang, Xiaolong Wang. Prime editing: a search and replace tool with versatile base changes [J]. Hereditas(Beijing), 2022, 44(11): 993-1008.
[8]	Yuting Han, Bowen Xu, Yutong Li, Xinyi Lu, Xizhi Dong, Yuhao Qiu, Qinyun Che, Ruibao Zhu, Li Zheng, Xiaochen Li, Xu Si, Jianquan Ni. The cutting edge of gene regulation approaches in model organism Drosophila [J]. Hereditas(Beijing), 2022, 44(1): 3-14.
[9]	Guangwu Yang, Yuan Tian. The F-box gene Ppa promotes lipid storage in Drosophila [J]. Hereditas(Beijing), 2021, 43(6): 615-622.
[10]	Dingwei Peng, Ruiqiang Li, Wu Zeng, Min Wang, Xuan Shi, Jianhua Zeng, Xiaohong Liu, Yaoshen Chen, Zuyong He. Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs [J]. Hereditas(Beijing), 2021, 43(3): 261-270.
[11]	Na Wang, Zhilian Jia, Qiang Wu. RFX5 regulates gene expression of the Pcdhα cluster [J]. Hereditas(Beijing), 2020, 42(8): 760-774.
[12]	Guoling Li, Shanxin Yang, Zhenfang Wu, Xianwei Zhang. Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals [J]. Hereditas(Beijing), 2020, 42(7): 641-656.
[13]	Yingnan Chen, Jing Lu. Application of CRISPR/Cas9 mediated gene editing in trees [J]. Hereditas(Beijing), 2020, 42(7): 657-668.
[14]	Xia Li, Wan Shi, Lizhao Geng, Jianping Xu. Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes [J]. Hereditas(Beijing), 2020, 42(6): 556-564.
[15]	Siyuan Liu, Guoqiang Yi, Zhonglin Tang, Bin Chen. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements [J]. Hereditas(Beijing), 2020, 42(5): 435-443.

Overview of patents on targeted genome editing technologies and their implications for innovation and entrepreneurship education in universities

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments